Oramed Pharmaceuticals
ORMP
#9014
Rank
NZ$0.21 B
Marketcap
NZ$5.42
Share price
-5.26%
Change (1 day)
39.74%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): NZ$98.84 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are NZ$2 Million. In 2024 the company made an earning of -NZ$25.2 Million a decrease over its 2023 earnings that were of NZ$11.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$98.84 M-492.33%
2024 -NZ$25.2 Million-311.47%
2023 NZ$11.91 M-119.45%
2022 -NZ$61.25 Million39.17%
2021 -NZ$44.02 Million73.93%
2020 -NZ$25.31 Million18.53%
2019 -NZ$21.35 Million-16.62%
2018 -NZ$25.61 Million38.32%
2017 -NZ$18.51 Million12.51%
2016 -NZ$16.46 Million25.01%
2015 -NZ$13.17 Million18.18%
2014 -NZ$11.14 Million39.72%
2013 -NZ$7.98 Million46.4%
2012 -NZ$5.45 Million128.32%
2011 -NZ$2.39 Million-51.47%
2010 -NZ$4.92 Million35.21%
2009 -NZ$3.64 Million
2007 -NZ$5.72 Million607.04%
2006 -NZ$0.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
NZ$34.85 B 35,654.86%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$15.21 B 15,508.83%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-NZ$0.87 Billion-989.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$0.12 Billion-217.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-NZ$46.09 Million-147.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel